Hyperprolactinemia induces hypogonadism by inhibiting gonadotropin-releasing hormone pulsatile secretion and, consequently, follicle-stimulating hormone, luteinizing hormone, and testosterone pulsatility. This leads to spermatogenic arrest, impaired motility, and sperm quality and results in morphologic alterations of the testes similar to those observed in prepubertal testes. Men with hyperprolactinemia present more frequently with a macroadenoma than a microadenoma. Symptoms directly related to hypogonadism are prevalent. In men hypogonadism leads to impaired libido, erectile dysfunction, diminished ejaculate volume, and oligospermia. It is present in 16% of patients with erectile dysfunction and in approx 11% of men with oligospermia. Tr...
The outcome of 24 months of cabergoline treatment on prolactin (PRL) normalization, tumor shrinkage,...
A 60-years old patient was admitted for mamillary pain for several weeks, without galactorrhea. Erec...
Prolactinomas account for approximately 50% of all pituitary adenomas coming to medical attention an...
Hyperprolactinemia induces hypogonadism by inhibiting gonadotropin-releasing hormone pulsatile secre...
Objective: To explore the evaluation, treatment and impact of hyperprolactinaemia on male infertilit...
Prolactinomas are the most frequent pituitary tumors and their frequency varies with age and sex, oc...
BACKGROUND: Alterations of sperm number and motility are found in hyperprolactinaemic men. Cabergoli...
This open longitudinal study investigated the prevalence of depressed sexual potency by monitoring e...
This open longitudinal study investigated the prevalence of depressed sexual potency by monitoring e...
This open longitudinal study investigated the prevalence of depressed sexual potency by monitoring e...
The aim of this study was to evaluate the effects of a chronic treatment with the non-ergot-derived ...
Prolactinomas in men have several peculiar features that distinguish them from female PRL-secreting ...
Prolactin (PRL) exerts independent hypertrophic effects on prostate in in vivo and in vitro experime...
This study evaluated the effects of chronic treatment with cabergoline (CAB), a new, potent and long...
textabstractIn this thesis some effects of PRL on reproductive functions have been investigated PRL-...
The outcome of 24 months of cabergoline treatment on prolactin (PRL) normalization, tumor shrinkage,...
A 60-years old patient was admitted for mamillary pain for several weeks, without galactorrhea. Erec...
Prolactinomas account for approximately 50% of all pituitary adenomas coming to medical attention an...
Hyperprolactinemia induces hypogonadism by inhibiting gonadotropin-releasing hormone pulsatile secre...
Objective: To explore the evaluation, treatment and impact of hyperprolactinaemia on male infertilit...
Prolactinomas are the most frequent pituitary tumors and their frequency varies with age and sex, oc...
BACKGROUND: Alterations of sperm number and motility are found in hyperprolactinaemic men. Cabergoli...
This open longitudinal study investigated the prevalence of depressed sexual potency by monitoring e...
This open longitudinal study investigated the prevalence of depressed sexual potency by monitoring e...
This open longitudinal study investigated the prevalence of depressed sexual potency by monitoring e...
The aim of this study was to evaluate the effects of a chronic treatment with the non-ergot-derived ...
Prolactinomas in men have several peculiar features that distinguish them from female PRL-secreting ...
Prolactin (PRL) exerts independent hypertrophic effects on prostate in in vivo and in vitro experime...
This study evaluated the effects of chronic treatment with cabergoline (CAB), a new, potent and long...
textabstractIn this thesis some effects of PRL on reproductive functions have been investigated PRL-...
The outcome of 24 months of cabergoline treatment on prolactin (PRL) normalization, tumor shrinkage,...
A 60-years old patient was admitted for mamillary pain for several weeks, without galactorrhea. Erec...
Prolactinomas account for approximately 50% of all pituitary adenomas coming to medical attention an...